ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997